| Unadjusteda | Adjusted analyses for DRG 541/542 versus short-term MVb | |||
---|---|---|---|---|---|
 | Short-term MV | DRG 541/542 | Between group difference (95% CI) | t | P |
ADLs | Â | Â | Â | Â | Â |
   Preadmission | 1.2 (1.9) | 0.9 (1.8) | -0.3 (-0.6 to +0.04) | -1.70 | 0.09 |
   2 months | 2.5 (2.1) | 4.1 (1.9) | 1.6 (1.0 to 2.2) | 5.81 | < 0.0001 |
   6 months | 1.9 (2.1) | 2.8 (2.1) | 0.9 (0.3 to 1.5) | 3.29 | 0.003 |
   12 months | 1.6 (2.0) | 2.3 (2.1) | 0.7 (0.2 to 1.2) | 2.97 | 0.005 |
IADLs | Â | Â | Â | Â | Â |
   Preadmission | 2.4 (2.8) | 2.1 (2.7) | -0.4 (-0.9 to +0.1) | -1.41 | 0.16 |
   2 months | 4.8 (2.4) | 5.7 (2.1) | 0.9 (0.4 to 1.4) | 3.60 | 0.0006 |
   6 months | 3.7 (2.6) | 5.2 (2.4) | 1.5 (0.8 to 2.2) | 4.20 | 0.0003 |
   12 months | 3.4 (2.7) | 4.8 (2.6) | 1.4 (0.9 to 2.0) | 4.86 | < 0.0001 |
SF-36 physical function | Â | Â | Â | Â | Â |
   Preadmission | 56 (38) | 61 (37) | 5 (-2 to +12) | 1.39 | 0.17 |
   2 months | 29 (28) | 15 (23) | -14 (-19 to -8) | -5.03 | < 0.0001 |
   6 months | 42 (33) | 28 (30) | -14 (-22 to -6) | -3.69 | 0.0006 |
   12 months | 46 (34) | 31 (31) | -15 (-22 to -7) | -3.98 | 0.0002 |
SF-36 role physical | Â | Â | Â | Â | Â |
   Preadmission | 53 (42) | 59 (43) | 6 (-3 to +14) | 1.30 | 0.20 |
   2 months | 26 (30) | 19 (25) | -7 (-13 to -1) | -2.48 | 0.01 |
   6 months | 44 (35) | 36 (32) | -8 (-16 to -1) | -2.20 | 0.03 |
   12 months | 46 (36) | 41 (34) | -5 (-14 to +4) | -1.21 | 0.23 |